Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas

The effects of cardiac disease on the intestine have been reported in humans but not in dogs. We investigated the effects of myxomatous mitral valve disease (MMVD), which is capable of causing congestion and tissue hypoperfusion, on the intestine in Chihuahuas, a breed frequently encountered in clin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: R. Araki, K. Iwanaga, Kazunori Ueda, M. Isaka
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/899ce3d513c4450aa398a2efb7e3aa9c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:899ce3d513c4450aa398a2efb7e3aa9c
record_format dspace
spelling oai:doaj.org-article:899ce3d513c4450aa398a2efb7e3aa9c2021-11-30T12:06:09ZIntestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas2297-176910.3389/fvets.2021.777579https://doaj.org/article/899ce3d513c4450aa398a2efb7e3aa9c2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fvets.2021.777579/fullhttps://doaj.org/toc/2297-1769The effects of cardiac disease on the intestine have been reported in humans but not in dogs. We investigated the effects of myxomatous mitral valve disease (MMVD), which is capable of causing congestion and tissue hypoperfusion, on the intestine in Chihuahuas, a breed frequently encountered in clinical practice as the preferred breed for MMVD. In this study, 69 Chihuahuas were divided into four groups based on echocardiography and chest radiography: 19 healthy Chihuahuas (H) and 50 Chihuahuas with MMVD classified according to the ACVIM consensus (stage B1, B2, C/D). In all the cases, serum intestinal fatty acid-binding protein (I-FABP) and D/L-lactate concentrations, markers of intestinal mucosal injury, were measured. I-FABP was significantly higher in stage C/D Chihuahuas than in other groups (p < 0.05), and stage B2 was significantly higher than H (p < 0.05). D-lactate was significantly increased in stages B2 and C/D compared to H and stage B1 (p < 0.05). L-lactate was significantly higher in stage C/D Chihuahuas than in any other group (p < 0.05), and stage B2 was significantly higher than that in H and stage B1 (p < 0.05). Intestinal mucosal injury risk was significantly higher in Chihuahuas with heart failure due to MMVD, suggesting that the risk could increase with worsening heart disease. This is the first study to investigate the intestinal complications of MMVD, and further investigations a needed in the future.R. ArakiR. ArakiR. ArakiK. IwanagaKazunori UedaM. IsakaFrontiers Media S.A.articleChihuahuasD-lactateintestinal complicationintestinal fatty acid-binding proteinintestinal mucosal injury markersmyxomatous mitral valve diseaseVeterinary medicineSF600-1100ENFrontiers in Veterinary Science, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Chihuahuas
D-lactate
intestinal complication
intestinal fatty acid-binding protein
intestinal mucosal injury markers
myxomatous mitral valve disease
Veterinary medicine
SF600-1100
spellingShingle Chihuahuas
D-lactate
intestinal complication
intestinal fatty acid-binding protein
intestinal mucosal injury markers
myxomatous mitral valve disease
Veterinary medicine
SF600-1100
R. Araki
R. Araki
R. Araki
K. Iwanaga
Kazunori Ueda
M. Isaka
Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
description The effects of cardiac disease on the intestine have been reported in humans but not in dogs. We investigated the effects of myxomatous mitral valve disease (MMVD), which is capable of causing congestion and tissue hypoperfusion, on the intestine in Chihuahuas, a breed frequently encountered in clinical practice as the preferred breed for MMVD. In this study, 69 Chihuahuas were divided into four groups based on echocardiography and chest radiography: 19 healthy Chihuahuas (H) and 50 Chihuahuas with MMVD classified according to the ACVIM consensus (stage B1, B2, C/D). In all the cases, serum intestinal fatty acid-binding protein (I-FABP) and D/L-lactate concentrations, markers of intestinal mucosal injury, were measured. I-FABP was significantly higher in stage C/D Chihuahuas than in other groups (p < 0.05), and stage B2 was significantly higher than H (p < 0.05). D-lactate was significantly increased in stages B2 and C/D compared to H and stage B1 (p < 0.05). L-lactate was significantly higher in stage C/D Chihuahuas than in any other group (p < 0.05), and stage B2 was significantly higher than that in H and stage B1 (p < 0.05). Intestinal mucosal injury risk was significantly higher in Chihuahuas with heart failure due to MMVD, suggesting that the risk could increase with worsening heart disease. This is the first study to investigate the intestinal complications of MMVD, and further investigations a needed in the future.
format article
author R. Araki
R. Araki
R. Araki
K. Iwanaga
Kazunori Ueda
M. Isaka
author_facet R. Araki
R. Araki
R. Araki
K. Iwanaga
Kazunori Ueda
M. Isaka
author_sort R. Araki
title Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
title_short Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
title_full Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
title_fullStr Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
title_full_unstemmed Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
title_sort intestinal complication with myxomatous mitral valve diseases in chihuahuas
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/899ce3d513c4450aa398a2efb7e3aa9c
work_keys_str_mv AT raraki intestinalcomplicationwithmyxomatousmitralvalvediseasesinchihuahuas
AT raraki intestinalcomplicationwithmyxomatousmitralvalvediseasesinchihuahuas
AT raraki intestinalcomplicationwithmyxomatousmitralvalvediseasesinchihuahuas
AT kiwanaga intestinalcomplicationwithmyxomatousmitralvalvediseasesinchihuahuas
AT kazunoriueda intestinalcomplicationwithmyxomatousmitralvalvediseasesinchihuahuas
AT misaka intestinalcomplicationwithmyxomatousmitralvalvediseasesinchihuahuas
_version_ 1718406633461121024